- Karnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)Wedding pics: Mouni Roy marries Suraj Nambiar in South Indian ceremony73rd Republic Day Parade 2022 - In Pictures
World No.1 Iga Swiatek came back from 0-3 down to save a match point at 5-3 in the decider
- ‘These last few days’: Chhetri shares emotional post heading into final international game
- FIH Pro League: Harmanpreet scores hat-trick as Indian men’s hockey team beats Argentina 5-4
- Europe tour: Indian junior women’s hockey team seal 2-0 victory against Dutch club
- Indian junior men’s and women’s hockey teams leave for tour of Europe
- First Serve, AITA Partner to empower athletes through Wheelchair Tennis Championship
SC directs daily dose regime for TB treatment Last Updated : 23 Jan 2017 03:49:06 PM IST (File photo)
In a big boost to the tuberculosis control programme, the Supreme Court on Monday said all new tuberculosis patients will get doses of drugs on daily basis instead of thrice a week.
Directing daily doses of fixed drugs combination treatment, Chief Justice Jagdish Singh Khehar, Justice N.V. Ramana and Justice D.Y. Chandrachud said all patients who were getting treatment under thrice-a-week-dose schedule would switch over to daily doses regimen in nine months.
The bench ordered the switch over following a PIL by Raman Kakkar, who is associated with the revised national TB control programme.
The court order came even as Additional Solicitor General Maninder Singh, appearing for the central government, told the court that the new regime could be implemented only in a phased manner.IANS For Latest Updates Please-
Join us on
Follow us on
172.31.16.186